Leptin and the metabolic syndrome in patients with myotonic dystrophy type 1

Acta Neurologica Scandinavica

Volumn 121, Issue 2, 2010, Pages 94-98

  Rakocevic Stojanovic, V ^a   Peric, S ^a   Lavrnic, D ^a   Popovic, S ^a   Ille, T ^b   Stevic, Z ^a   Basta, I ^a   Apostolski, S ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Leptin; Metabolic syndrome; Myotonic dystrophy type 1

Indexed keywords

CHOLESTEROL; GLUCOSE; INSULIN; LEPTIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MYOTONIC DYSTROPHY; MYOTONIC DYSTROPHY TYPE 1; ORAL GLUCOSE TOLERANCE TEST; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MYOTONIC DYSTROPHY; SEX CHARACTERISTICS; TRIGLYCERIDES;

EID: 74349100546     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2009.01237.x     Document Type: Article

References (24)

1. Brook JD, McCurrach ME, Harley HG et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 1992 68 : 799 808.
2. Morone A, Pegoraro E, Angelini C, Zammarchi E, Marconi G, Hoffman EP. RNA metabolism in myotonic dystrophy. J Clin Invest 1997 7 : 1691 1698.
3. Savkur RS, Philips AV, Cooper TA et al. Insulin receptor splicing alteration in myotonic dystrophy type 2. Am J Hum Genet 2004 74 : 1309 1313.
4. Dick KA, Margolis JM, Day JW, Ranum LP. Dominant non-coding repeat expansions in human disease. Genome Dyn 2006 1 : 67 83.
5. Johansson Å., Olsson T, Cederquist K et al. Abnormal release of incretins and cortisol after oral glucose in subjects with insulin-resistant myotonic dystrophy. Eur J Endocrinol 2002 146 : 397 405.
6. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Diabet Med 1998 15 : 539 553.
7. Björntorp P, Rosmond R. The metabolic syndrome - a neuroendocrine disorder? Br J Nutr 2000 83 (Suppl. 1 S49 57.
8. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994 372 : 425 432.
9. Rentsch J, Chiesi M. Regulation of ob gene mRNA levels in cultured adipocytes. FEBS Lett 1996 379 : 55 9.
10. Anubhuti AS. Leptin and its metabolic interactions: an update. Diabetes Obes Metab 2008 10 : 973 993.
11. Kolaczynski JW, Ohannessian J, Considine RV, Marco C, Caro JF. Response of leptin to short-term and prolonged overfeeding in humans. J Clin Endocrinol Metab 1996 91 : 4162 4165.
12. Slieker LJ, Sloop KW, Surface PL et al. Regulation of expression of ob mRNA and protein by glucocorticoids and cAMP. J Biol Chem 1996 271 : 5301 5304.
13. Kirchgessner T, Uysal K, Wiesbrock S, Marino M, Hotamisligil G. Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Invest 1997 100 : 2777 2782.
14. Gomez JM, Martinez-Matos JA. Leptin after IGF-I generation test in a patient with hypopituitarism and myotonic dystrophy disease. Pituitary 1999 1 : 121 123.
15. Stephens TW, Basinski M, Bristow PK et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995 377 : 530 532.
16. Frühbeck G. Intracellular signalling pathways activated by leptin. Biochem J 2006 393 (Pt 1 7 20.
17. Pierroz DD, Catzeflis C, Aebi AC et al. Chronic administration of neuropeptide Y into the lateral ventricle inhibits both the pituitary-testicular axis and growth hormone and insulin-like growth factor I secretion in intact adult male rats. Endocrinology 1996 137 : 3 12.
18. Milewicz T, Krzysiek J, Janczak-Saif A, Sztefko K. Leptin correlates with distribution of fatty tissue and plasma levels of insulin, testosterone and tumor necrosis factor alpha in perimenopausal women with increased testosterone level and central location of body fat. Przegl Lek 2006 63 : 640 644.
19. Gomez JM, Molina A, Fernandez-Castaner M, Casamitjana R, Martinez-Matos JA, Soler J. Insulin regulation of leptin synthesis and secretion in humans: the model of myotonic dystrophy. Clin Endocrinol 1999 50 : 569 575.
20. Harper PS. Myotonic dystrophy, 2nd edn. London : WB Saunders, 1989.
21. Johansson Å., Ahren B, Forsberg H, Olsson T. Testosterone and diurnal rhythmicity of leptin, TNF- and TNF-II receptor in insulin-resistant myotonic dystrophy patients. Inter J Obes 2002 26 : 1386 1392.
22. Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 : 412 419. (Pubitemid 15018832)
23. Gomez JM, Molina A, Fernandez-Castaner MA, Soler J. Leptin in type 2 diabetic or myotonic dystrophic women. Horm Metab Res 2001 33 : 246 249.
24. Haffner SM, Miettinen H, Stern M. The homeostasis model in the San Antonio Heart Study. Diabetes Care 1997 20 : 1087 1092.